Michalski Jacob E, Schwartz David A
Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
J Inflamm Res. 2021 Jan 5;13:1305-1318. doi: 10.2147/JIR.S280958. eCollection 2020.
Idiopathic pulmonary fibrosis is an etiologically complex interstitial lung disease characterized by progressive scarring of the lungs with a subsequent decline in lung function. While much of the pathogenesis of IPF still remains unclear, it is now understood that genetic variation accounts for at least one-third of the risk of developing the disease. The single-most validated and most significant risk factor, genetic or otherwise, is a gain-of-function promoter variant in the gene. While the functional impact of these IPF risk variants at the cellular and tissue levels are areas of active investigation, there is a growing body of evidence that these genetic variants may influence disease pathogenesis through modulation of innate immune processes.
特发性肺纤维化是一种病因复杂的间质性肺病,其特征是肺部进行性瘢痕形成,随后肺功能下降。虽然特发性肺纤维化的许多发病机制仍不清楚,但现在人们明白,基因变异至少占患该病风险的三分之一。最经证实且最显著的风险因素,无论是否为基因因素,是该基因中一个功能获得性启动子变体。虽然这些特发性肺纤维化风险变体在细胞和组织水平上的功能影响是积极研究的领域,但越来越多的证据表明,这些基因变体可能通过调节先天性免疫过程来影响疾病发病机制。